| DJ. SPEICHER*1, A LAM2, NW. JOHNSON1 1School of
Dentistry and Oral Health, Griffith University, Southport, Australia.
2School of Medicine, Griffith University, Southport, Australia
Objectives: HHV-8, regarded as the aetiological agent of
Kaposi’s sarcoma (KS), multicentric Castleman’s disease (MCD) and primary
effusion lymphoma (PEL) has been extensively characterized worldwide but
overlooked in Australia as HAART has greatly reduced the incidence of KS as
an AIDS-defining condition. Globally, there is marked variability in the
prevalence of KS. In Australia the prevalence of both HIV (0.1%) and of
HHV-8 appears to be low, but there are no population data for the latter.
Our overall objective is to fully characterize HHV-8 in Australia, as part
of a multinational study which includes high-prevalence parts of the world.
In the latter, oral KS is common. This pilot study describes HHV-8 in KS and
MCD biopsies from both HIV-positive and –negative Australian patients.
Methods: 21 biopsies from 16 patients (males:females,
15:1) with a mean age of 55.7 years (28.2-88.6 years) with KS or MCD
diagnosed between 2004 and 2008 were examined by haematoxylin and eosin
(H&E) staining and immunohistochemistry (IHC) targeting the HHV-8 LANA-1
protein (NCL-HHV8-LNA; Novacastra). Positive controls were sections from
embedded BCBL-1 cell lines. Confirmation of HHV-8 IHC staining was sought by
polymerase chain reaction (PCR) targeting ORF73 and ORF26.
Results: HHV-8 was detected in two HIV-negative elderly
males (78 and 88 years) with classic KS nodules on lower extremities and 10
HIV-positive males with a mean age of 4510 years. Biopsies of AIDS-KS
positive for HHV-8 were taken from the epidermis except one from the
duodenum. HHV-8 was also detected in a cervical lymph node from an
HIV-positive male with MCD. PCR for HHV-8 ORF73 and ORF26 was confirmational
in tissue positive by IHC.
Conclusions: HHV-8 was detected in KS and MCD biopsies in
Australia by IHC and confirmed by PCR. This study reports the presence of
HHV-8 from Australia and lays the foundation for determining the Australian
HHV-8 strain and seroprevalence. Our ongoing collaborative studies in Africa
include many oral lesions: those in India none, as KS is extremely rare in
the subcontinent. |